Mohsen Ayati - Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Reza Nowroozi - Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Afshin Mortazavi - Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Solmaz Ohadian Moghadam - Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Background: BCG therapy is used as a treatment in bladder cancer. Methods: Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. Results and Conclution: He was treated successfully with antitubercular therapy and prednisolone.

BCG therapy; hepatic granulomatous tuberculosis; bladder cancer